Biol Psychiatry Cogn Neurosci Neuroimaging
February 2023
Background: Individualized and reliable biomarkers are crucial for diagnosing Alzheimer's disease (AD). However, lack of accessibility and neurobiological correlation are the main obstacles to their clinical application. Machine learning algorithms can effectively identify personalized biomarkers based on the prominent symptoms of AD.
View Article and Find Full Text PDF